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 High serum levels of carbohydrate antigen19-9 (CA19-9) 
have been detected in patients with pancreatic cancer and 
described in several recent case reports of patients with 
hydronephrosis. However, the mechanism of high serum levels 
of CA19-9 among hydronephrosis cases remains to be eluci-
dated. In this study, we established a mouse unilateral ureteral 
obstruction (UUO) model to investigate the expression of 
CA19-9 protein in renal tissue. To investigate the progression 
of hydronephrosis following UUO, MR urography and patho-
logical analysis were performed. CA19-9 expression was ex-
amined by immunohistochemistry and western blot analysis. 
MR urography revealed that the grade of pelvic dilatation 
increased in a time dependent manner. Pathologically, both 
interstitial cellular infiltration and fibrosis were detected 
from the second to the fourteenth day after surgery in UUO 
mice. CA19-9 was detected in the UUO kidney after the sec-
ond day. The immunoblot analysis revealed that the elevated 
expression of CA19-9 was demonstrated at an early stage of 
obstructive nephropathy. Our study shows that the ureteral 
obstructed kidney is dominated by cell infiltration and in-
duced fibrosis. The selective expression of CA19-9 was de-
tected in renal fibrous tissue. Based on these findings, the 
level of CA19-9 might be a good indicator for onset of renal fi-
brosis induced by obstruction. 
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Introduction
in the development of interstitial renal fibrosis.' One of 
the selectin family, L-selectin, is thought to play an 
important role in the pathogenesis of this disorder.2 
 A carbohydrate antigen (CA 19-9) is a high molecular 
weight glycoprotein, which is a ligand for L-selectin,3 
and is detected by a monoclonal antibody that is pro-
duced by immunizing mice with human colon cancer 
cells.' The antigenic determinant is a sialylated deriva-
tive of the Lewisa (Lea) blood group antigen.' CA 19-9 
is known to be elevated in the serum of patients with 
intraabdominal malignancies, particularly in those who 
suffer from pancreatic cancer.' In' contrast, patients di-
agnosed as having non-malignant disease, such as pul-
monary fibrosis, and hemochromatosis which is pathol-
ogically noted as hepatic fibrosis, were found to have 
associated marked elevations of serum CA 19-9.'• 3 
These data support the idea that fibrotic disease may be 
associated with high serum CA 19-9 level. The CA 19-9 
serum level is also elevated in hydronephrosis.9-12 
Unilateral ureteral obstruction (UUO) is a well estab-
lished experimental model of renal hydronephrosis 
leading to interstitial fibrosis." Previous studies have 
investigated the molecular and cellular mechanisms of 
interstitial fibrosis in UUO,14 and the accumulation of 
leucocytes within the interstitium of the kidney is well 
recognized in the course of hydronephrosis.15 
 In the present study, we examined the relevance of 
CA19-9 expression in the progression of interstitial fi-
brosis caused by unilateral ureteral obstruction in mice 
and found that CA19-9 expression was elevated in 
fibrotic renal tissue.
 A series of specific interactions between adhesion 
molecules expressed on circulating leucocytes and their 
ligands on endothelial and other cell types are involved
Address Correspondence: Koichiro Nomata, M.D. 
Department of Urology, Nagasaki University School of Medicine, 
1-7-1 Sakamoto, Nagasaki 852-8501, Japan 
TEL: +81-95-849-7340, FAX: +81-95-849-7343 
E-mail: knomata@net. nagasaki-u.ac.jp
Materials and methods
Unilateral obstruction of ureter 
 Five-weeks-old male ddy mice in each experiment were 
used and underwent unilateral obstruction of the ureter. 
Briefly, mice were anesthesized by an intraperitoneal 
injection of pentobarbital (5.0,u g/kg body wt) and right
ureter was identified through a small dorsal lumbar in-
cision and was ligated by using 5-0 silk at the point of 
upper the ureter. The sham operation to provide con-
trol kidneys involved a similar incision. After indi-
cated days, obstructed kidneys were morphologically 
examined by MR urography.
MRI examination 
 Experiments were performed on the 1st day (n=5), 
2nd day (n=5), 3rd day (n=5), 7th day (n=5) and 
14th day (n= 5) after UUO surgery. The sham operated 
groups (n=5) acted as controls. Magnetic resonance 
imaging (MRI) analysis was performed by a 9.41 unit 
DMX400WB (Bruker, Rheinstetten, Germany) to study 
the morphological change in UUO.16 The repetition time 
(TR) and echo time (TE) were determined for T1-and 
T2-weighted images. Multiple coronal T2-weighted im-
ages were obtained with a 5cm field of view, 512 x 512 
matrix, 6 acquisitions, and 1 mm slice thickness.
Tissue preparation and pathological experiment 
 Kidney specimens were fixed in 10% buffered formalin 
and embedded in paraffin. The 4 u m thick sections 
were stained with hematoxylin-eosin and for pathologi-
cal examination. For protein assay and western blotting, 
the kidney specimens were removed and snap-frozen 
in liquid nitrogen until use.
Immunohistochemical analysis of CA19-9 
 Immunohistochemical analysis of CA 19-9 expression 
was performed using the Histo mouse plus kit' 
(Zymed Laboratories Inc, San Francisco, CA) and a 
mouse monoclonal antibody to human CA 19-9 (DAKO, 
Kyoto, Japan). Briefly, paraffin-embedded specimens 
were sectioned and placed on silan coated glass slides 
(Matsunami, Osaka, Japan). Deparaffinized sections 
were then placed in 0.1M citrate buffer (PH6.0) and 
treated with 0.3% HZ O2 in methanol for 20 min to 
block endogeneous peroxidase activity. After washing 
with phosphate-buffered saline (PBS), sections were in-
cubated with the blocking solution (Zymed). The pri-
mary antibody, mouse monoclonal antibody CA 19-9, 
was applied to the sections at a dilution of 1:50. These 
sections were then incubated for one hour at room 
temperature. After washing in PBS, the sections were 
incubated with the second antibody of the Histo mouse 
plus kit (Zymed) for 30 min at room temperature. After 
appropriate washings, the sections were incubated in 
streptoavidin-peroxidase (Zymed) for 15 min. The act of 
peroxidase were visualized by the addition of Regent3
(Zymed)." Finally, the sections were counterstained 
with methyl green.
Western blot of CA19-9 
 A whole kidney was homogenized by a Polytron 
homogenizer (Kinematica, Littau/luzern, Switzerland), 
then lysed in 10% SDS, protease inhibitor cocktail tablets 
(Roche Diagnostics Gmbh, Mannheim, Germany) in PBS 
buffer and sonicated for 30 sec on ice. Human colon 
cancer cells (colo205) acting as a positive control" were 
cultured in RPMI1640 supplemented with 10% FBS, and 
lysed with bromomix buffer (Wako, Osaka Japan). 
Then the protein concentration was determined in the 
supernatant by using the Bio Rad detergent compati-
ble protein assay kit' (Bio Rad Laboratories, Tokyo, 
Japan). Next, 80,u g of protein in each lysate was sepa-
rated by 5% SDS-polyacrylamide gel electrophoresis 
and transferred to PVDF membranes (Millipore Japan, 
Tokyo, Japan) affixed with the blocking solutions of the 
Histo mouse plus kit' (Zymed). The membranes were 
then incubated with anti CA 19-9 monoclonal antibodies 
(DAKO Japan) diluted 50-fold with blocking solution 
(Zymed) at room temperature overnight. After washing 
with PBS containing Tween20, the membranes were in-
cubated with the second antibody of the Histo mouse 
plus kit' (Zymed) for two hours at room temperature, 
and streptoavidin-peroxidase (Zymed) for one hour at 
room temperature. After extensive washing, the proteins 
were visualized using the ECL-chemiluminescence detec-
tion kit (Amersham Pharmacia Biotech Inc, Piscataway, 
NJ)19
Results
MRI study of UUO mouse kidney 
 Unilateral ureteral obstruction was performed and 
morphological change was monitored by MR urography 
(Fig. 1). It was found that the renal pelvis was dilated 
time-dependently, and the intensity of renal parenchyma 
was increased and volume of renal parenchyma was 
decreased as well.
Histopathological change in the obstructed kidney 
 Sections obtained from the kidneys of UUO mice 
were histological examined. Fig 2 B shows that sections 
at day 1 revealed a slight dilatation of distal convo-
luted tubules (DCTs), a minimal change in proximal 
convoluted tubules (PCTs), and a slight cellular infil-
tration of the interstitium when compared with sections
of sham operated kidney (Fig. 2A). Renal tissue at 
day 2 revealed dilatation of PCT and DCT, and mild 
inflammatory cell infiltration was observed in the 
interstitium (Fig. 2C). A day 3 dilatation of PCTs and 
inflammatory cells were more evident than that of the 
day 2 specimens (Fig. 2D). Thin and atrophic paren-
chyma with partial coagulation necrosis and dilatation 
of the pelvis at 7 post operative days. On the 14th day 
increased necrosis of the pyramidal area, widened in-
terstitial fibrosis and atrophied parenchyma were ob-
served (Fig. 2F).
Figure 1. MR urography T2-weighted representative uni-
lateral ureteral obstruction (UUO) in the mouse kidney. 
(A) Sham operated mouse kidney. (B, C, D) Renal pelvis 
was extended on the 1st day, 2nd day and 3rd day after 
UUO respectively. (E, F) Renal parenchyma was thin on 
the 7th day after UUO and was thinner on the 14th day.
Immunohistological study of CA19-9 
 It has been reported that serum CA 19-9 is elevated 
in the patients with hydronephrosis. These reports 
suggest that CA 19-9 may be produced in obstructive 
kidney. To clarify the localization of CA19-9 protein 
expression in renal tissue, immunohistochemical staining
Figure 2. Histopathological change in HE staining ob-
served in the unilateral ureteral obstruction (UUO) of the 
mouse kidney. (A) Representative sections of a kidney 
from a sham operated mouse. (B) On the 1st day after 
UUO, there was slight dilatation of the DCT but minimal 
change in the PCT, and slight cellular infiltration of the 
interstitium. (C) Dilatation of the PCT and DCT, and mild 
inflammatory cell infiltration in the interstitial tissue was 
observed on the second day after UUO. (D) Dilatation of 
the PCT became more evident on the 3rd day after UUO. 
(E) Atrophy of the parenchyma, and interstitial fibrosis 
are evident on the 7th day after UUO. (F) Widening of in-
terstitial fibrosis and atrophy of tubular are revealed on 
the 14th day after UUO. (X 100)
of CA 19-9 was performed. Figure 3 shows that almost 
no staining was observed in sham operated (Fig. 3A) 
or UUO renal tissue at day 1 (Fig. 3B). At day 2 the rep-
resentative appearance of the staining of CA 19-9 in the 
UUO kidneys (Fig. 3C). CA19-9 immunoreactivity was 
observed in the periglomerular and peritubular interstitium 
of the obstructed kidney. In the sections of renal tissue 
obtained at day 7 (Fig. 3E) and day 14 (Fig. 3F), 
CA19-9 immunoreactivity was observed in the majority 
of expanded peritubular spaces. Without anti CA 19-9 
Antibody, no staining was observed (data not shown).
Figure 3. Immunostaining of CA 19-9. (A, B) No staining 
was detected in the sham operated mouse kidney or on the 
1st day after surgery in the UUO mouse kidney. (C, D) 
Immunolocalization of the peritubular interstitial areas on 
the 2nd and 3rd day after UUO. (E) Immunolocalization of 
the peritubular interstitial fibrotic area on the 7th day after 
UUO. (F) Tubular interstitial fibrotic area was stained on 
the 14th day after UUO. (X200)
Western blot analysis of CA 19-9 
 To quantify the expression levels of CA 19-9 in the 
renal tissue, immunoblot analysis was performed with 
total protein extracts of renal tissues. Figure 4 shows 
that CA 19-9 protein was observed in the extract of ob-
structed kidney from 2 to 14 days after UUO. The ex-
tract from colo205 cells was used as a positive control 
and (-actin bands served as an indicator of loaded pro-
tein amounts. No band was detected in the extract of 
sham operated kidney.
Discussion
 In the present study, the authors demonstrated that 
the protein expression of CA 19-9 in the obstructed
Figure 4. Western blotting of CA 19-9 in the unilateral 
ureteral obstructed mouse kidney and the colo205 cells act-
ing as a positive control. Expression of CA19-9 at approxi-
mately 250Kd immunoreactive band was detected on the 2nd, 
3rd, 7th, and 14th day after UUO in the mouse kidney and 
colo205 cells. g -actin was expressed in all specimens.
kidneys of UUO mice was localized in the peritubular 
interstitial space. Dilatation of PCT and DCT became 
significant 2 days after ureteral ligation and thereafter, 
renal interstitial fibrosis progressed. The expression of 
CA 19-9 was observed in renal interstitial tissue. These 
results are consistent with the previous reports of pul-
monary and hepatic fibrosis. 
 L-selectin is a member of selectin family and is in-
volved in site-specific lymphocyte adhesion." Selectins 
bind to sialyl Le' (sLe'), sialyl Lea (sLea) and related car 
bohydrates. During kidney allograft rejection, peritubular 
capillary endothelium reacts strongly with the anti-sLex 
antibody. Turunen et al reported that the ligand for L-
selectin was induced during kidney rejection character-
ized by lymphocyte infiltration." This pathological fea-
ture was similar to that of the acute obstructed kidney. 
 Moriyama et al reported that fibrotic changes in the 
interstitium became significant 4 days after obstruction 
was induced in the kidneys, and a significant increase 
in type I collagen mRNA also appeared 4 days after the 
onset of ureteral obstruction." Hence, CA 19-9 up-
regulated expression was induced two days after ob-
struction. These data suggest that the onset of CA 19-9 
expression might be related to early events of intersti-
tial renal fibrosis. 
 The site of CA 19-9 production in fibrous renal tissue 
is not clarified yet. There are possibllities that either 
infiltrated monocytes or peritubular endothelial cells, 
or both might produce CA 19-9. Theoretically, two major 
mechanisms have been suggested for the induction of 
endothelial cells to become sLea and sLea positive. 
Firstly, they could synthesize sialyl Lewis epitopes di-
rectly, which would require the presence of functional 
a 1,3 fucosyltransferase (a 1,3 Fuc-Ts) or a 1,4 fucoslt-
ransferase ( a 1,4 Fuc-Ts) and a 2,3 sialyltransferase 
activities in endothelial cells. Secondly, these epitopes 
could be absorbed passively from the blood. The genes 
encoding a 1,3 Fuc-Ts form a family and 5 human and 
3 mouse a 1,3 Fuc-Ts genes have been cloned.23 The 
mouse a 1,3 Fuc-Ts can synthesize the LeX epitope and 
mouse a 1,3 Fuc-Ts transcripts were abundant in the 
mouse kidney .2' However, whether mouse a 1,3 Fuc-Ts 
has the ability of a 1,4 fucosylation remains to be con-
firmed. In the present study, the expression of CA 19-9 
protein was elevated in hydronephrotic mouse kidney. 
The Fuc-Ts activity might be increased in the kidney 
after hydronephrosis. Alternatively, infiltrated monocytes 
may produce CA 19-9 in a similar way that has been 
described above. 
 To date, the CA 19-9 producing cells in obstructed 
renal tissue has not yet been identified. It may be possible 
that CA 19-9 levels as an indicator of renal fibrosis in-
duced by upper urinary tract obstruction. However, the 
elevated expression of CA 19-9 in transitional cell carci-
noma has recently been reported. Thus, careful exami-
nation must be taken whether urothelial carcinoma is 
associated or not. 
 In conclusion, the present study showed that the 
ureteral obstructed kidney is dominated by cell infiltration 
and induced fibrosis. The selective expression of CAI 9-9 
was detected in renal fibrotic area and the expression 
of CA 19-9 protein was higher in the early stage of fi-
brosis. Given these results, CA 19-9 might be an effec-
tive marker for the onset of renal fibrosis induced by 
urinary obstruction.
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